CO2018010549A2 - Composición administrable oralmente - Google Patents
Composición administrable oralmenteInfo
- Publication number
- CO2018010549A2 CO2018010549A2 CONC2018/0010549A CO2018010549A CO2018010549A2 CO 2018010549 A2 CO2018010549 A2 CO 2018010549A2 CO 2018010549 A CO2018010549 A CO 2018010549A CO 2018010549 A2 CO2018010549 A2 CO 2018010549A2
- Authority
- CO
- Colombia
- Prior art keywords
- orally administrable
- pharmaceutically acceptable
- composition orally
- composition
- forming
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporciona una composición micelar administrable oralmente. La composición comprende un agente farmacéutico encapsulado en micelas formadas por al menos un compuesto formador de micelas en un solvente acuoso farmacéuticamente aceptable que comprende un salicilato de metal alcalino y un edetato farmacéuticamente aceptable combinado con al menos un agente formador de película fisiológicamente aceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/059,444 US11166912B2 (en) | 2016-03-03 | 2016-03-03 | Orally administrable composition |
PCT/CA2017/050250 WO2017147691A1 (en) | 2016-03-03 | 2017-02-27 | Orally administrable composition |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2018010549A2 true CO2018010549A2 (es) | 2018-12-14 |
Family
ID=59722571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2018/0010549A CO2018010549A2 (es) | 2016-03-03 | 2018-10-01 | Composición administrable oralmente |
Country Status (11)
Country | Link |
---|---|
US (1) | US11166912B2 (es) |
EP (1) | EP3423037A4 (es) |
AU (1) | AU2017225927B2 (es) |
BR (1) | BR112018067586A2 (es) |
CL (1) | CL2018002474A1 (es) |
CO (1) | CO2018010549A2 (es) |
CU (1) | CU20180097A7 (es) |
IL (1) | IL261479B2 (es) |
PE (1) | PE20190318A1 (es) |
WO (1) | WO2017147691A1 (es) |
ZA (1) | ZA201805802B (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11033493B2 (en) | 2013-12-02 | 2021-06-15 | Intelgenx Corp. | Film dosage form with extended release mucoadhesive particles |
US20220079881A1 (en) * | 2016-03-03 | 2022-03-17 | Ctt Pharma Inc. | Orally Administrable Composition |
EP3222292A1 (en) | 2016-03-03 | 2017-09-27 | Heidelberg Pharma GmbH | Amanitin conjugates |
EP3528784B1 (en) * | 2016-10-21 | 2023-08-02 | APIRX Pharmaceutical USA, LLC | Suppositories comprising cannabinoids |
CA3096062A1 (en) * | 2018-04-03 | 2019-10-10 | Pure Green, Llc | Tablet or composition having n-acyl ethanolamine and cannabinoid |
US20190336457A1 (en) * | 2018-04-18 | 2019-11-07 | Leading Edge Pharms Inc. | Compositions and methods for alleviating pain |
US10751299B2 (en) * | 2018-09-04 | 2020-08-25 | Babak Ghalili | Cannabinoid and menthol compositions and methods |
US11185526B2 (en) | 2018-09-04 | 2021-11-30 | Babak Ghalili | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods |
US11602504B2 (en) | 2018-11-05 | 2023-03-14 | Intelgenx Corp. | Lipophilic active oral film formulation and method of making the same |
US10588871B1 (en) | 2019-06-28 | 2020-03-17 | Nexzol Pharma, Inc. | Transdermal formulation for the treatment of pain and/or inflammation |
GB2587621A (en) * | 2019-09-30 | 2021-04-07 | Biofilm Ltd | Oral films and a methods for the manufacture and delivery thereof |
CN112569220B (zh) * | 2019-09-30 | 2023-03-07 | 云南汉盟制药有限公司 | 四氢次***酚在制备用于治疗肺动脉高压药物中的应用及含有四氢次***酚的药物组合物 |
CN111117125A (zh) * | 2019-12-30 | 2020-05-08 | 武汉轻工大学 | 一种复合抗菌膜及其制备方法 |
CN113116868B (zh) * | 2019-12-31 | 2022-08-19 | 汉义生物科技(北京)有限公司 | 四氢次***酚在肺动脉高压的预防和/或治疗中的应用 |
WO2021243188A1 (en) * | 2020-05-29 | 2021-12-02 | Hemp Synergistics | Powderized cannabis oil |
US11786475B2 (en) * | 2020-07-22 | 2023-10-17 | Soluble Technologies Inc. | Film-based dosage form |
WO2022027053A1 (en) * | 2020-07-28 | 2022-02-03 | Wsmef, Llc | Micelle preparations of full-spectrum hemp oil for treating type ii diabetes, reducing inflammation during covid-19, and improving sleep quality |
WO2022122471A1 (en) | 2020-12-09 | 2022-06-16 | I+Med S. Coop. | Composition comprising sea water and cannabinoid loaded submicroparticles for pharmaceutical, nutraceutical and cosmetic applications |
US12011470B2 (en) | 2021-07-28 | 2024-06-18 | Clint Sorensen | Micelle preparations of full-spectrum hemp oil |
WO2023039587A2 (en) * | 2021-09-13 | 2023-03-16 | Arriaga Adan | Cannabinoid composition and method of using the same |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL117773A (en) * | 1996-04-02 | 2000-10-31 | Pharmos Ltd | Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability |
US5800832A (en) | 1996-10-18 | 1998-09-01 | Virotex Corporation | Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces |
US6350458B1 (en) * | 1998-02-10 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Mixed micellar drug deliver system and method of preparation |
CA2229286C (en) | 1998-02-10 | 2005-07-26 | Generex Pharmaceuticals Inc. | Mixed micellar delivery system and method of preparation |
US6221378B1 (en) | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
US6312665B1 (en) | 1998-12-21 | 2001-11-06 | Generex Pharmaceuticals Incorporated | Aerosol formulations for buccal and pulmonary application |
AU4445201A (en) * | 2000-03-30 | 2001-10-08 | Generex Pharmaceuticals Inc. | Method for administering insulin to the buccal region |
EE200200567A (et) | 2000-03-31 | 2004-06-15 | Pfizer Products Inc. | Uued piperasiini derivaadid |
US6398589B1 (en) | 2000-09-07 | 2002-06-04 | Richard A. Congelliere | Device for restricting operation of an electrical tool |
AU2002952597A0 (en) | 2002-11-11 | 2002-11-28 | Schering-Plough Pty. Limited | Topical parasiticide formulations and methods of treatment |
JP2009517410A (ja) | 2005-11-30 | 2009-04-30 | ジェネレクス ファーマシューティカルズ インコーポレイテッド | 経口吸収される医薬製剤および投与方法 |
WO2009015456A1 (en) | 2007-07-30 | 2009-02-05 | Generex Pharmaceuticals Inc. | Pharmaceutical formulation in mixed micellar form and dispenser for oral delivery of agents as a spray |
CA2624110C (en) | 2008-03-27 | 2010-11-09 | Pankaj Modi | A rapidly-dissolving orally administrable wafer formulation |
US8623401B2 (en) * | 2008-03-27 | 2014-01-07 | Fenwafe Inc. | Wafer formulation |
US20110305768A1 (en) | 2008-07-01 | 2011-12-15 | The Johns Hopkins University | Quick-dissolving oral thin film for targeted delivery of therapeutic agents |
WO2013009928A1 (en) | 2011-07-11 | 2013-01-17 | Organic Medical Research | Cannabinoid formulations |
RU2016129536A (ru) | 2013-10-31 | 2018-01-31 | Фулл Спектрум Лабораториз, Лтд. | Препараты на основе терпенов и каннабиноидов |
-
2016
- 2016-03-03 US US15/059,444 patent/US11166912B2/en active Active
-
2017
- 2017-02-27 CU CU2018000097A patent/CU20180097A7/es unknown
- 2017-02-27 PE PE2018001609A patent/PE20190318A1/es unknown
- 2017-02-27 BR BR112018067586A patent/BR112018067586A2/pt active Search and Examination
- 2017-02-27 AU AU2017225927A patent/AU2017225927B2/en not_active Ceased
- 2017-02-27 IL IL261479A patent/IL261479B2/en unknown
- 2017-02-27 EP EP17759030.4A patent/EP3423037A4/en active Pending
- 2017-02-27 WO PCT/CA2017/050250 patent/WO2017147691A1/en active Application Filing
-
2018
- 2018-08-29 ZA ZA2018/05802A patent/ZA201805802B/en unknown
- 2018-08-30 CL CL2018002474A patent/CL2018002474A1/es unknown
- 2018-10-01 CO CONC2018/0010549A patent/CO2018010549A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL261479A0 (en) | 2018-10-31 |
ZA201805802B (en) | 2019-06-26 |
IL261479B1 (en) | 2023-05-01 |
EP3423037A4 (en) | 2019-11-27 |
CL2018002474A1 (es) | 2019-01-18 |
IL261479B2 (en) | 2023-09-01 |
US20170252300A1 (en) | 2017-09-07 |
PE20190318A1 (es) | 2019-03-04 |
AU2017225927A1 (en) | 2018-10-04 |
WO2017147691A1 (en) | 2017-09-08 |
CU20180097A7 (es) | 2019-05-03 |
US11166912B2 (en) | 2021-11-09 |
IL261479A (en) | 2021-03-25 |
BR112018067586A2 (pt) | 2019-01-08 |
AU2017225927B2 (en) | 2021-07-01 |
EP3423037A1 (en) | 2019-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2018010549A2 (es) | Composición administrable oralmente | |
PE20190738A1 (es) | Formulacion novedosa para administracion por via oral | |
CL2020002252A1 (es) | Formulación oftálmica. | |
CL2015003072A1 (es) | Formulaciones de liberación prolongada de colchicina y métodos de uso de las mismas. | |
EP3452026A4 (en) | METHODS OF MANUFACTURE, COMPOSITIONS AND MEDICAL APPLICATIONS OF ORAL-ADDED CANNABIS-BASED PHARMACEUTICAL PRODUCTS | |
AR081542A1 (es) | Composiciones de emulsiones farmaceuticas con bajo contenido de aceite que comprenden un progestageno | |
RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
AR087871A1 (es) | Una composicion farmaceutica de rapida disolucion | |
CU24486B1 (es) | Dispersión sólida amorfa que comprende taxano, tabletas comprendiendo la misma y método para prepararla | |
WO2020044119A3 (en) | Oral formulations of lavender and cannabinoids | |
CL2016002560A1 (es) | Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación. | |
EA201690810A1 (ru) | Мягкие пастилки, содержащие экстракт куркумы | |
CR20150297A (es) | Producto de comicronización que comprende acetato de ulipristal | |
AR075180A1 (es) | Formulaciones orales solidas de una pirido-pirimidinona | |
CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
CL2016000047A1 (es) | Productos de confitería a base de grasa. | |
BR112017019364A2 (pt) | dispersões sólidas | |
PE20151282A1 (es) | Combinacion de medicamentos que comprenden fenilefrina y paracetamol | |
ES2561813T3 (es) | Aplicación tópica de nimesulida y tiocolchicósido | |
BR112015021769A2 (pt) | composições farmacêuticas compreendendo um agente ativo | |
TR201721700A2 (tr) | Saksagli̇pti̇ni̇n ağizda dağilan formülasyonlari | |
CL2019001555A1 (es) | Preparación farmacéutica y método para su fabricación. | |
AR094203A1 (es) | Formulacion farmaceutica en n-[5-[2-(3,5-dimetoxifenil)etil]-2h-pirazol-3-il]-4-[(3r,5s)-3,5-dimetilpiperazin-1-il]benzamida | |
ES2475942B1 (es) | Composición farmacéutica de citrato de sildenafilo en forma de solución acuosa | |
BR112021015795A8 (pt) | Composição |